Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 183
B
Workshop Participants
WORKSHOP ON BLOOD BANK OPERATIONS
July 23-24, 1994
James B. AuBuchon, M.D.
Medical Director
Department of Pathology
Dartmouth-Hitchcock Medical Center
Jay Epstein, M.D.
Center for Biologics Evaluation
and Research
Food and Drug Administration
William Andrew Heaton, M.D.
Irwin Memorial Blood Center
Paul Holland, M.D.
Director
Sacramento Medical Foundation
P. Ann Hoppe
Assistant to the Director
Office of Blood Research and Review
Food and Drug Administration
Claude Lenfant, M.D.
Director
National Heart, Lung and Blood Institute
James MacPherson
Executive Director
Council of Community Blood Centers
Herb Perkins
Irwin Memorial Blood Center
James Reilly
Executive Director
American Blood Resources Association
Jenni Lee Robins
Director, Total Quality Management
New York Blood Center
George B. Schreiber, D.Sc.
Westat, Inc.
Ernest R. Simon, M.D.
Executive Vice President
Scientific, Medical and Technical Affairs
Blood Systems, Inc.
Edwin A. Steane, Ph.D.
Principal Officer
American Red Cross Blood Services
Charles Wallas, M.D.
Director, Blood Bank
Vanderbilt University Medical Center
183
OCR for page 184
184
BLOOD AND BLOOD PRODUCTS: SAFETY AND RISK
WORKSHOP ON RISK AND REGULATION
January 23-24, 1995
Lew Barker
Efficacy Trials Branch
Vaccine and Prevention Research
Program
Division of AIDS, NIAID, NIH
Celso Bianco, M.D.
Vice President, Medical Affairs
New York Blood Center
Penny Chan, Ph.D.
Commission of Inquiry
Blood Systems in Canada
Toronto, Ontario
Harry W. Chen
HemaSure Inc.
Marlborough, MA
Eileen Church
Communications Manager
American Association of Blood Banks
Marcia Crosse
Program Evaluation and Methodology
Division
U.S. General Accounting Office
Jacqueline D'Alessio, Ph.D.
U.S. General Accounting Office
Leonard I. Friedman
American Red Cross
Holland Lab
Elizabeth Goss
Fox, Bennett & Turner
Washington, DC
Harold Kaplan, M.D.
University of Texas
Southwestern Medical Center
Kurt R. Kroemer
U.S. General Accounting Office
Jan Lane
American Red Cross
Karen Shoos Lipton
CEO
American Association of Blood Banks
Jane Mackey, MBA
Topeka Blood Bank, Inc.
James MacPherson
Executive Director
Council of Community Blood Centers
John McCray
HemaSure Inc.
Marlborough, MA
Brian McDonough
American Red Cross
Arlington, VA
Charles Mosher
Blood Centers of America, Inc.
East Greenwich, RI
Jean Otter
Director of Regulatory Affairs
American Association of Blood Banks
Mary K. Pendergast
Deputy Commissioner and
Senior Advisor to the Commissioner
Food and Drug Administration
Barbara Peoples
American Red Cross
Holland Lab
OCR for page 185
APPENDIX B
Mark Philip
IMMUNO US, Inc.
Rochester, MI
Beatrice Pierce
National Hemophilia Foundation
Rancho Santa Fe, CA
William H. Portman
The Institute for Transfusion Medicine
Pittsburgh, PA
James Reilly
Executive Director
American Blood Resources Association
Miriam Sparrow, Esq.
New York Blood Center, Inc.
Edwin Steane, Ph.D.
ICCBBA
Eugene Timm
IMMUNO US, Inc.
Rochester, MI
Peter Tomasulo, M.D.
TM Consulting, Inc.
McLean, VA
Lee Ann Weitekamp
The Blood Center of Southeastern
Wisconsin
Milwaukee, WI
WORKSHOP ON MANAGING THREATS
TO TlIE BLOOD SUPPLY
September 21-22, 1995
Lew Barker
Efficacy Trials Branch
Vaccine and Prevention Research
Program
Division of AIDS, NIAID, NIH
Patricia Bezjak
Chief Operating Officer
Metropolitan Washington Blood Banks
Celso Bianco, M.D.
Vice President, Medical Affairs
New York Blood Center
Eileen Church
Communications Manager
American Association of Blood Banks
Brian P. Conway, Esq.
Bayer Corporation
185
Richard J. Davey, M.D.
Chief Medical Officer
American Red Cross
Rob Dickstein
Director, Regulatory Affairs
Pall Corporation
Sandra Ellisor
Ortho Diagnostic Systems, Inc.
Susan Frantz-Bohn
Division of Congressional and Public
Affairs
Center for Biologics Research and
Evaluation
Food and Drug Administration
Steve Friedman
Dechert, Price, & Rhoads
OCR for page 186
186
Eric Goosby
Office of HIV/AIDS Policy
Public Health Service
Elizabeth Goss
Fox, Bennett & Turner
Washington, DC
William J. Hammes
Associate Counsel
Bayer Corporation
Harriet Newman, (MT) ASCP
Donor Advocate
Virginia Blood Services
Nancy Newman
Knapp, Petersen & Clark
Jean Otter
Director of Regulatoy Affairs
American Association of Blood Banks
Stephen Redhead
Congressional Research Service
Library of Congress
James Reilly
Executive Director
American Blood Resources Association
BLOOD AND BLOOD PRODUCTS: SAFER AND RISK
Paul Schmidt, M.D.
Head, Transfusion Medicine
Transfusion Medicine Academic Center
Florida Blood Services
Toby Simon, M.D.
President and CEO
Blood Systems, Inc.
Harold C. Sox, Jr., M.D.
Chairman, Department of Medicine
Dartmouth-Hitchcock Medical Center
Miriam Sparrow, Esq.
New York Blood Center, Inc.
Jane Starkey
Deputy Director
Council of Community Blood Centers
Ron Welborn
Community Bioresources, Inc.
Edward Wolf
Senior Associate General Council
American Red Cross
Sam Wortham
Group Vice President
Pall Corporation
Representative terms from entire chapter:
red cross
